The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MPN Advances Day 2019 | MPN Advances Day 2019: highlights
Nauman Butt
• 15 Nov 2019
Nauman Butt, MB BCh, MRCP, MD, FRCPath, Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool, UK, talks to us about the key topics presented at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.
